Biliary tract cancer

Current Opinion in Gastroenterology

Volumn 12, Issue 5, 1996, Pages 460-465

  Cendan, Juan C ^a   Zlotecki, Robert A ^a   Vauthey, Jean Nicolas ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE DUCT CARCINOMA; BILIARY TRACT CANCER; GENE MUTATION; LIVER RESECTION; MOLECULAR BIOLOGY; ONCOGENE RAS; POINT MUTATION; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

EID: 0029850277     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-199609000-00009     Document Type: Short Survey

References (40)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 1996, 65:5-27.
2. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T: Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994, 107:1147-1153.
3. Malats N, Porta M, Piñol JL, Corominas JM, Rifa J, Real FX for the PANK-ras Project Investigators: Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. J Clin Oncol 1995, 13:1679-1686. K-ras mutations were independently associated with poorer survival.
4. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G: K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct Cancer 1996, 77:452-458.
5. Kimura K, Ohto M, Saisho H, Unozawa T, Tsuchiya Y, Morita M, Ebara M, Matsutani S, Okuda K: Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 1985, 89:1258-1265.
6. Diamantis I, Karamitopoulou E, Perentes E, Zimmermann A: p53 immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology 1995, 22:774-779. Overexpression of p53 was noted in gallbladder and distal bile duct cancer by immunohistochemistry and was associated with significantly worse survival.
7. Tan CK, Podila PV, Taylor JE, Nagorney DE, Wiseman GA, Gores GJ, LaRusso NF: Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition. Gastroenterology 1995, 108:1908-1916.
8. Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 1995, 55:2756-2760. Point mutations in cell-cycle protein inhibitors were found in primary biliary tract cancers and cell lines of biliary tract cancers.
9. Terada T, Ohta T, Minato H, Nakanuma Y: Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 1995, 26:746-752.
10. Pandey M, Gautam A, Shukla VK: ABO and Rh blood groups in patients with cholelithiasis and carcinoma of the gallbladder. BMJ 1995, 310:1639.
11. Yamada N, Chung YS, Arimoto Y, Sawada T, Seki S, Sowa M: Establishment of a new human extrahepatic bile duct carcinoma cell line (OCUCh-LM1) and experimental liver metastatic model. Br J Cancer 1995, 71:543-548.
12. Henson DE, Albores-Saavedra J, Corle D: Carcinoma of the extranepatic bile ducts: histologic types, stage of disease, grade and survival rates. Cancer 1992, 70:1498-1501.
13. Vauthey JN, Blumgart LH: Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994, 14:109-114.
14. Hayashi S, Miyazaki M, Kondo Y, Nakajima N: Invasive growth patterns of hepatic hilar ductal carcinoma: a histologic analysis of 18 surgical cases. Cancer 1994, 73:2922-2929.
15. Nimura Y, Hayakawa N, Hasegawa H, Kamiya J, Yamase H, Kondo H, Shionoya S: Surgical problems of carcinoma of the hepatic hilum in view of the extent of cancer in the caudate branches. Nippon Geka Gakkai Zasshi 1986, 87:1094-1097.
16. Bhuiya MMR, Nimura Y, Kamiya J, Kondo S, Nagino M, Hayakawa N: Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 1993, 17:653-657.
17. Farley DR, Weaver AL, Nagorney DM: "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative resection. Mayo Clin Proc 1995, 70:425-429.
18. Cucchiara G, Gandini G, Simonetti G, Bracci F, Daffinà A: Palliative treatment of extrahepatic bile duct tumors. J Surg Oncol [Suppl] 1993, 3:154-157.
19. Launois B, Catheline JM, Maddern GJ: Intrahepatic anastomoses for malignant and benign biliary obstruction. Arch Surg 1995, 130:137-142.
20. Henson DE, Albores-Saavedra J, Corle D: Carcinoma of the gallbladder: histologic types, stage of disease, grade, and survival rates. Cancer 1992, 70:1493-1497.
21. Shirai Y, Yoshida K, Tsukada K, Muto T: Inapparent carcinoma of the gallbladder. Ann Surg 1992, 215:326-331.
22. Onoyama H, Yamamota M, Tseng A, Ajiki T, Saitoh Y: Extended chole cystectomy for carcinoma of the gallbladder. World J Surg 1995, 19:758-763. Survival is improved after extended cholecystectomy for gallbladder cancer compared with simple cholecystectomy alone.
23. Bloechle C, Izbicki JR, Passlick B, Gawad K, Passow C, Rogiers X, Schreiber HW, Broelsch CE: Is radical surgery in locally advanced gallbladder carcinoma justified? Am J Gastroenterol 1995, 90:2195-2200. Even advanced-stage gallbladder cancer may benefit from resection if complete microscopic resection can be achieved.
24. Pradeep R, Kaushik SP, Sikora SS, Bhattacharya BN, Pandey CM, Kapoor VK: Predictors of survival in patients with carcinoma of the gallbladder. Cancer 1995, 76:1145-1149.
25. Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N, Myerson RJ: Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 1994, 55:239-245.
26. Pitt HA, Nakeeb A, Abrams RA, Coleman J, Piantadosi S, Yeo CJ, Lillemoe KD, Cameron JL: Perihilar cholangiocarcinoma: postoperative radiotherapy does not improve survival. Ann Surg 1995, 221:788-798. Detailed analysis of a single institution's experience with adjuvant radiotherapy.
27. Schoenthaler R, Phillips TL, Castro J, Efird JT, Better A, Way LW: Carcinoma of the extrahepatic bile ducts: the University of California at San Francisco experience. Ann Surg 1994, 19:267-274.
28. Berson AM, Castro JR, Petti P, Phillips TL, Gauger GE, Gutin P, Collier JM, Henderson SD, Baken K: Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience, Int J Radiat Oncol Biol Phys 1988, 15:559-565.
29. Cameron JL, Pitt HA, Zinner MJ, Kaufman SL, Coleman J: Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg 1990, 159:91-98.
30. Grove MK, Hermann RE, Vogt DP, Broughan TA: Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg 1991, 161:454-458.
31. Bowling TE, Hatfield ARW, Spittle MF, Solano J: A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gastroenterology 1995, 108(suppl):A406.
32. Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S: Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg 1990, 14:535-544.
33. Bismuth H, Nakache R, Diamond T: Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992, 215:31-38.
34. Ogura Y, Mizumoto R, Tabata M, Matsuda S, Kusuda T: Surgical treatment of carcinoma of the hepatic duct confluence: analysis of 55 resected carcinomas. World J Surg 1993, 17:85-93.
35. Baer HU, Stain SC, Dennison AR, Eggers B, Blumgart LH: Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 1993, 217:20-27.
36. Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM: Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993, 128:871-879.
37. Washburn WK, Lewis WD, Jenkins RL: Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995, 30:270-276. This study is another illustration of the trend toward more frequent hepatic resection for proximal cholangiocarcinoma.
38. Miyagawa S, Makuuchi M, Kawasaki S: Outcome of extended right hepatectomy after biliary drainage in hilar bile duct cancer. Arch Surg 1995, 130:759-763. These authors' thoughtful approach to patients requiring hepatic resection for proximal cholangiocarcinoma is supported by favorable outcome data.
39. Kuvshinoff BW, Armstrong JG, Fong Y, Schupak K, Getradjman G, Heffernan N, Blumgart LH: Palliation of irresectabte hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995, 82:1522-1525.
40. Tsujino K, Landry JC, Smith RG, Keller JW, Williams WH, Davis LW: Definitive radiation therapy for extrahepatic bile duct carcinoma. Radiology 1995, 196:275-280.